4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000056
EVP Strategy & Corp Dev sold 4,203 shares at an average $130.21 ($547,259)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Dolan Matthew Vincent · EVP Strategy & Corp Dev
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-15 | Sale : show line 1 in the form 10b5-1 | −1,886 | $129.18 | $243,641 | 46,684 | D |
| 2024-03-15 | Sale : show line 2 in the form 10b5-1 | −1,314 | $130.77 | $171,832 | 45,370 | D |
| 2024-03-15 | Sale : show line 3 in the form 10b5-1 | −1,003 | $131.39 | $131,785 | 44,367 | D |
| Open-market sales · 4,203 sh · avg $130.21 · $547,259 | ||||||
Loading xslF345X05/edgardoc.xml…